CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
86 hedge funds and large institutions have $98.5M invested in Cascadian Therapeutics, Inc. in 2014 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 17 reducing their positions, and 13 closing their positions.
Holders
86
Holders Change
–
Holders Change %
0%
% of All Funds
2.3%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
14
Increased
35
Reduced
17
Closed
13
Calls
$463K
Puts
$201K
Net Calls
+$262K
Net Calls Change
-$552K
Top Buyers
1 |
BI
1
BVF Inc
San Francisco,
California
|
$26.1M |
2 |
ACA
2
Avoro Capital Advisors
New York
|
$5.68M |
3 |
CS
3
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
$1.41M |
4 |
BC
4
Broadfin Capital
New York
|
$3.8M |
5 |
![]()
5
JPMorgan Chase & Co
New York
|
$1.25M |